Marta Schirripa
0000-0001-8316-4411
Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico
3 papers found
Refreshing results…
Circulating microRNA analysis in a prospective co-clinical trial identifies MIR652-3p as a response biomarker and driver of regorafenib resistance mechanisms in colorectal cancer
A polymorphism within the R-spondin 2 gene predicts outcome in metastatic colorectal cancer patients treated with FOLFIRI/bevacizumab: data from FIRE-3 and TRIBE trials
AMPK variant, a candidate of novel predictor for chemotherapy in metastatic colorectal cancer: A meta‐analysis using TRIBE, MAVERICC and FIRE3
Missing publications? Search for publications with a matching author name.